| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $69.3M | -31.8% |
| Cost of Revenue | $57.6M | -31.5% |
| Gross Profit | $11.7M | -33.1% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $14.0M | -0.5% |
| Operating Income | -$4.7M | -871.5% |
| Pre-tax Income | -$5.3M | -1007.1% |
| Income Tax | $0 | — |
| Net Income | -$5.3M | -1007.1% |
| EPS (Basic) | -$0.15 | -400.0% |
| EPS (Diluted) | -$0.15 | -400.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | -31.6% |
| Accounts Receivable | $8.1M | -1.8% |
| Inventory | $3.4M | -40.7% |
| Current Assets | $38.2M | +3.1% |
| Total Assets | $57.1M | -3.5% |
| Current Liabilities | $9.6M | -32.0% |
| Long-term Debt | $8.8M | +4.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$659K | -115.7% |
| Investing Cash Flow | -$8.5M | -75.6% |
| Financing Cash Flow | $4.3M | -42.1% |
| $20.2M |
| -24.3% |
| Stockholders' Equity | $37.0M | +13.5% |